Skip to content

The Researchers Would Like to Conduct a Trial Using Gamified Exercise to Increase Cardiorespiratory Fitness and Intention to Quit Smoking Among Hardcore Smokers Who Are Also Physically Inactive.

Gamified Exercise for Hardcore Smokers: A Quasi-Experimental Protocol for Improving Cardiorespiratory Fitness and Smoking Cessation

Status
Enrolling by invitation
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07390695
Enrollment
60
Registered
2026-02-05
Start date
2025-09-01
Completion date
2026-09-01
Last updated
2026-02-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiorespiratory Fitness or Endurance, Smoking Cessation

Keywords

exercise, gamification, cardiorespiratory fitness, smoking cessation

Brief summary

The goal of this quasi-experiment is to learn if a gamified exercise works to improve cardiorespiratory fitness in physically inactive hardcore smokers. It will also learn about the effects of smoking cessation. The main questions it aims to answer are: * Does a gamification of a structured training program improve the cardiorespiratory fitness and smoking cessation behavior among smokers? * Is there any mediating effect from the level of physical activity between a gamified exercise and cardiorespiratory fitness? * Will the smokers engage in the gamified exercise within the 12-week intervention? This is a no-control group. The quasi-experiment will be conducted within one group (paired data).

Interventions

BEHAVIORALGamification of a structured exercise program

A structured exercise program with FITT-VP principles is gamified and delivered to 60 physically inactive hardcore smokers.

Sponsors

Gadjah Mada University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

One group quasi-experiment. Using one group that is involved in the whole stages of research (pre-test, intervention, post-test, and follow-up).

Eligibility

Sex/Gender
MALE
Age
17 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

* hardcore smokers (min 20 cigarettes per day) * being active smokers at least 1 year * physically active (MET less than 600 MET minutes per week)

Exclusion criteria

* having any medical conditions that limit them to participation in a program training

Design outcomes

Primary

MeasureTime frameDescription
Estimated Maximal Oxygen Uptake (VO2Max) Measured by the Cooper 12-Minute Run TestBaseline (Week 0) and post-intervention (Week 13)Estimated cardiorespiratory fitness assessed using the Cooper 12-Minute Run Test. Participants are instructed to run or walk as far as possible within 12 minutes. The total distance covered (in meters) is used to estimate maximal oxygen uptake (VO2Max), expressed in milliliters per kilogram per minute (mL/kg/min). Higher VO2Max values indicate better cardiorespiratory fitness.

Secondary

MeasureTime frameDescription
Level of Physical Activity Measured by the World Health Organization Global Physical Activity Questionnaire (GPAQ)Baseline (Week 0) and post-intervention (Week 13)Physical activity level assessed using the World Health Organization Global Physical Activity Questionnaire (GPAQ). The GPAQ measures physical activity across work, transport, and leisure domains. Total physical activity is calculated in metabolic equivalent task minutes per week (MET-minutes/week). Higher scores indicate higher levels of physical activity.
Intention to Quit Smoking Measured by the Intention to Quit Smoking Scale (IQSS)Baseline (Week 0) and post-intervention (Week 13)Smoking cessation intention was assessed using the Intention to Quit Smoking Scale (IQSS) developed by Söyler and Yorulmaz (2024). The IQSS is a self-reported questionnaire consisting of multiple items rated on a Likert-type scale. Total scores range from 8 to 40, with higher scores indicating a stronger intention to quit smoking.

Countries

Indonesia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 6, 2026